EFFICACY OF DENOSUMAB IN PATIENTS WITH AROMATASE INHIBITOR INDUCED BONE LOSS

被引：0
|
作者：
Tsagareli, M. [1 ]
Giorgadze, E. [1 ]
Khachidze, N. [1 ]
Dolidze, N. [1 ]
Sulikashvili, T. [1 ]
Jeiranashvili, N. [1 ]
机构：
[1] Natl Inst Endocrinol, Tbilisi, Georgia
来源：
OSTEOPOROSIS INTERNATIONAL | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P235
引用
收藏
页码：S314 / S314
页数：1
相关论文
共 50 条
  • [1] Bone density loss in the view of a Aromatase inhibitor therapy in mamma carcinoma-patients (AIBL = Aromatase Inhibitor Induced Bone Loss)
    Hadji, P.
    Ziller, M.
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 2008, 68 (06) : 662 - 664
  • [2] MANAGEMENT OF AROMATASE-INHIBITOR-INDUCED BONE LOSS IN ELDERLY PATIENTS
    Mercieca, Cecilia
    Down, Megan
    Webb, Jackie
    Shipley, Jacqueline
    Bhalla, Ashok K.
    [J]. RHEUMATOLOGY, 2011, 50 : 71 - 71
  • [3] Management of Aromatase Inhibitor-Induced Bone Loss in Breast Cancer Patients
    Husnoo, N.
    Abbas, S.
    [J]. BRITISH JOURNAL OF SURGERY, 2016, 103 : 134 - 135
  • [4] EVALUATION AND TREATMENT OF AROMATASE INHIBITOR-INDUCED BONE LOSS
    Nassar, K.
    Assadi, R.
    Janani, S.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S179 - S179
  • [5] Aromatase inhibitor-induced bone loss osteosarcopenia in older patients with breast cancer: effects of the RANK/RANKL system's inhibitor denosumab vs. bisphosphonates
    Casabella, Andrea
    Paladin, Francesca
    Bighin, Claudia
    Ottaviani, Silvia
    Marelli, Cristina
    Ponzano, Marta
    Signori, Alessio
    Murdaca, Giuseppe
    Cutolo, Maurizio
    Molfetta, Luigi
    Nencioni, Alessio
    Paolino, Sabrina
    Del Mastro, Lucia
    Monacelli, Fiammetta
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2024,
  • [6] Efficacy of denosumab on bone mineral density in postmenopausal women with low bone mass and patients with breast cancer on adjuvant aromatase inhibitor (AI) therapy
    Bone, H. G.
    Ellis, G.
    Yuen, C. K.
    Kendler, D. L.
    Fan, M.
    Wang, H.
    Kim, D.
    Liu, Y.
    Dansey, R.
    Martin, J. San
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S38 - S38
  • [7] Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients
    Yee, Andrew J.
    Raje, Noopur S.
    [J]. CLINICAL INTERVENTIONS IN AGING, 2012, 7 : 331 - 338
  • [8] Aromatase Inhibitor-Associated Bone Loss
    Bryce, Jane
    Bauer, Martina
    Hadji, Peyman
    [J]. ONCOLOGY NURSING FORUM, 2011, 38 (03) : 273 - 276
  • [9] Prevention of Aromatase Inhibitor-Induced Bone Loss Using Risedronate: The SABRE Trial
    Van Poznak, Catherine
    Hannon, Rosemary A.
    Mackey, John R.
    Campone, Mario
    Apffelstaedt, Justus P.
    Clack, Glen
    Barlow, David
    Makris, Andreas
    Eastell, Richard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (06) : 967 - 975
  • [10] Management of bone loss induced by aromatase inhibitors
    Gnant, M
    [J]. CANCER INVESTIGATION, 2006, 24 (03) : 328 - 330
12345